Research results by the British drugs group AstraZeneca and the University of Oxford has revealed that their jointly-developed COVID-19 vaccine has shown “an average 70 percent...
A US biotech firm, Moderna Inc on Monday said preliminary data from an ongoing phase three study of its experimental COVID-19 vaccine showed it to be...
Synthego on Thursday secured a $100 million funding round, an investment that is expected to help produce reagents and cells supporting basic research and clinical trials....